TY - JOUR
T1 - Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles
AU - Ojima, Koichi
AU - Ono, Yasuko
AU - Ottenheijm, Coen
AU - Hata, Shoji
AU - Suzuki, Hidenori
AU - Granzier, Henk
AU - Sorimachi, Hiroyuki
N1 - Funding Information:
We are grateful to all the members of the Calpain Project (Rinshoken) for valuable support and discussions. This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology [MEXT.KAKENHI 18076007 to H.S.]; the Japan Society for the Promotion of Science [JSPS.KAKENHI 20500369 to K.O., 20370055 to H.S.]; the Ministry of Health, Labor and Welfare [Research Grant (20B-13) for Nervous and Mental Disorders to H.S.]; a Takeda Science Foundation research grant to H.S.; and the National Institutes of Health [NIH 062881 to H.G.].
PY - 2011/4/1
Y1 - 2011/4/1
N2 - Mutations in CAPN3/Capn3, which codes for skeletal muscle-specific calpain-3/p94 protease, are responsible for limb-girdle muscular dystrophy type 2A. Using "knock-in" (referred to as Capn3CS/CS) mice, in which the endogenous calpain-3 is replaced with a mutant calpain-3:C129S, which is a proteolytically inactive but structurally intact calpain-3, we demonstrated in our previous studies that loss of calpain-3 protease activity causes muscular dystrophy [Ojima, K. et al. (2010) J. Clin. Invest. 120, 2672-2683]. However, compared to Capn3-null (Capn3-/-) mice, Capn3 CS/CS mice showed less severe dystrophic symptoms. This suggests that calpain-3 also has a non-proteolytic function. This study aimed to elucidate the non-proteolytic functions of calpain-3 through comparison of Capn3 CS/CS mice with Capn3-/- mice. We found that calpain-3 is a component of the sarcoplasmic reticulum (SR), and that calpain-3 interacts with, but does not proteolyze, typical SR components such as ryanodine receptor and calsequestrin. Furthermore, Capn3CS/CS mice showed that the nonenzymatic role of calpain-3 is required for proper Ca2+ efflux from the SR to cytosol during muscle contraction. These results indicate that calpain-3 functions as a nonenzymatic element for the Ca2+ efflux machinery in the SR, rather than as a protease. Thus, defects in the nonenzymatic function of calpain-3 must also be involved in the pathogenesis of limb-girdle muscular dystrophy type 2A.
AB - Mutations in CAPN3/Capn3, which codes for skeletal muscle-specific calpain-3/p94 protease, are responsible for limb-girdle muscular dystrophy type 2A. Using "knock-in" (referred to as Capn3CS/CS) mice, in which the endogenous calpain-3 is replaced with a mutant calpain-3:C129S, which is a proteolytically inactive but structurally intact calpain-3, we demonstrated in our previous studies that loss of calpain-3 protease activity causes muscular dystrophy [Ojima, K. et al. (2010) J. Clin. Invest. 120, 2672-2683]. However, compared to Capn3-null (Capn3-/-) mice, Capn3 CS/CS mice showed less severe dystrophic symptoms. This suggests that calpain-3 also has a non-proteolytic function. This study aimed to elucidate the non-proteolytic functions of calpain-3 through comparison of Capn3 CS/CS mice with Capn3-/- mice. We found that calpain-3 is a component of the sarcoplasmic reticulum (SR), and that calpain-3 interacts with, but does not proteolyze, typical SR components such as ryanodine receptor and calsequestrin. Furthermore, Capn3CS/CS mice showed that the nonenzymatic role of calpain-3 is required for proper Ca2+ efflux from the SR to cytosol during muscle contraction. These results indicate that calpain-3 functions as a nonenzymatic element for the Ca2+ efflux machinery in the SR, rather than as a protease. Thus, defects in the nonenzymatic function of calpain-3 must also be involved in the pathogenesis of limb-girdle muscular dystrophy type 2A.
KW - calpainopathy
KW - limb-girdle muscular dystrophy type 2A
KW - protease
KW - proteolysis
KW - ryanodine receptor
UR - http://www.scopus.com/inward/record.url?scp=79952451731&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952451731&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2011.01.057
DO - 10.1016/j.jmb.2011.01.057
M3 - Article
C2 - 21295580
AN - SCOPUS:79952451731
SN - 0022-2836
VL - 407
SP - 439
EP - 449
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 3
ER -